1Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. Journal of the National Cancer Institute 1998; 90: 1774–86.
2Gertig D, Hunter DJ. Ovarian cancer. In: Adami HO, Hunter DJ, Trichopoulos D, eds. Textbook of Cancer Epidemiology. Oxford: Oxford University Press, 2002; 378–99.
3Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiology Biomarkers & Prevention 2005; 14: 98–107.
4Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocrine Reviews 1987; 8: 132–41.
5Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17-alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. New England Journal of Medicine 1996; 335: 617–23.
6Lukanova A, Lundin E, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, et al. . Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes & Control 2003; 14: 285–92.
7Dal Maso L, Augustin LS, Franceschi S, Talamini R, Polesel J, Kendal CW, et al. . Association between components of the insulin-like growth factor system and epithelial ovarian cancer risk. Oncology 2004; 67: 225–30.
8Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. Journal of Clinical Endocrinology 1997; 82: 2308–13.
9Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, et al. . Circulating levels of insulin-like growth factor-1 and risk of ovarian cancer. International Journal of Cancer 2002; 101: 549–54.
10Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemisto A, et al. . Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Molecular Cancer 2005; 4: 7.
11Holt S, Miller JC, Petocz P. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. American Journal of Clinical Nutrition 1997; 66: 1264–6.
12Ionescu-Tirgoviste C, Popa E, Sintu E, Mihalache N, Cheta D, Mincu I. Blood glucose and plasma insulin responses to various carbohydrates in type 2 (non-insulin-dependent diabetes). Diabetologia 1983; 24: 80–4.
13Jenkins DJ, Kendal CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, et al. . Glycemic index: overview of implications in health and disease. American Journal of Clinical Nutrition 2002; 76: 266S–73S.
14Ludwig DS. Dietary glycemic index and obesity. Journal of Nutrition 2000; 130: 280S–3S.
15Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values. American Journal of Clinical Nutrition 2002; 76: 5–56.
16Byrnes SE, Miller JCB, Denyer GS. Amylopectin starch promotes the development of insulin resistance in rats. Journal of Nutrition 1995; 125: 1430–7.
17Augustin LS, Polesel J, Bosetti C, Kendall CWC, La Vecchia C, Parpinel M, et al. . Dietary glycemic index, glycemic load and ovarian cancer risk: a case–control study in Italy. Annals of Oncology 2003; 14: 78–84.
18Trout D, Behall KM. Prediction of glycemic index among high-sugar, low-starch foods. International Journal of Food Sciences and Nutrition 1999; 50: 135–44.
19Wolever TMS, Brand-Miller JC. Sugars and blood glucose control. American Journal of Clinical Nutrition 1995; 62: 212S–27S.
20Terry PD, Miller AB, Jones JG, Rohan TE. Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study. European Journal of Cancer 2003; 39: 1157–64.
21Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study. 1. Breast cancer detection and death rates among women aged 40–49 years. Canadian Medical Association Journal 1992; 147: 1459–76.
22Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study. 2. Breast cancer detection and death rates among women aged 50–59 years. Canadian Medical Association Journal 1992; 147: 1477–88.
23Rohan TE, Hartwick W, Miller AB, Kandel RA. Immunohistochemical detection of c-erbB-2 and p-53 in benign breast disease and breast cancer risk. Journal of the National Cancer Institute 1998; 90: 1262–9.
24Jain M, Harrison L, Howe GR, Miller AB. Evaluation of a self-administered dietary questionnaire for use in a cohort study. American Journal of Clinical Nutrition 1982; 36: 931–5.
25Morgan AB, Jain M, Miller AB, Choi NW, Matthews V, Munan L, et al. . A comparison of dietary methods in epidemiologic studies. American Journal of Epidemiology 1978; 107: 488–98.
26Lajous M, Willett W, Lazcano-Ponce E, Sanchez-Zamorano LM, Hernandez-Avila M, Romieu I. Glycemic load, glycemic index, and the risk of breast cancer among Mexican women. Cancer Causes & Control 2005; 16: 1165–9.
27Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. American Journal of Epidemiology 1986; 124: 17–27.
28Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia, PA: Lippincott-Raven, 1998.
29McCann SE, Freudenheim JL, Marshall J, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. Journal of Nutrition 2003; 133: 1937–42.
30Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez Lira-Lira G, Escuerdo-De los Rios P, Hernandez-Avila M. Nutritional determinants of epithelial ovarian cancer risk: a case–control study in Mexico. Oncology 2002; 63: 151–7.
31Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, et al. . Prospective study of diet and ovarian cancer. American Journal of Epidemiology 1999; 149: 21–31.
32Bidoli E, La Vecchia C, Montella M, Dal Maso L, Conti E, Negri E, et al. . Nutrient intake and ovarian cancer: an Italian case–control study. Cancer Causes & Control 2002; 13: 255–61.
33Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M, et al. . Diet and ovarian cancer risk: a case–control study in Italy. International Journal of Cancer 2001; 93: 911–5.
34Willett WC, Stampfer MJ. Nutritional Epidemiology. New York: Oxford Univeristy Press, 1998.
35Dickinson S, Brand-Miller JC. Glycemic index, postprandial glycemia and cardiovascular disease. Current Opinion in Lipidology 2005; 16: 69–75.
36Colombani PC. Glycemic index and load – dynamic dietary guidelines in the context of diseases. Physiology & Behavior 2004; 83: 603–10.
37Brand-Miller JC. Glycemic load and chronic disease. Nutrition Reviews 2003; 61: S49–55.